Search Results: BRCA

Charity to make breast cancer (BRCA2) gene freely available across Europe

Cancer Research UK today secured a Europe-wide patent on the hereditary breast cancer gene BRCA2, in a move that will be welcomed by scientists across the continent. Cancer Research UK today secured a Europe-wide patent on the hereditary breast cancer gene BRCA2, in a move that will be welcomed by scientists across the continent.

11 February 2004

• Health & Medicine

BRCA1 gene points way to targeting breast cancer treatment

Testing tumours for the breast cancer gene BRCA1 could be a powerful way of predicting how patients will respond to chemotherapy, scientists from Breast Cancer Campaign and Cancer Research UK report. Testing tumours for the breast cancer gene BRCA1 could be a powerful way of predicting how patients will respond to chemotherapy, scientists from Breast Cancer Campaign and Cancer Research UK report.

25 September 2003

How mutant BRCA2 causes cancer

Scientists believe they have uncovered one of the cancer-causing secrets of the breast cancer gene BRCA2. Scientists believe they have uncovered one of the cancer-causing secrets of the breast cancer gene BRCA2.

20 November 2002

• Health & Medicine

Olaparib approved for 800 prostate and breast cancer patients in England

Olaparib, a targeted cancer drug discovered and developed with our funding, has been approved for hundreds of patients with certain breast and prostate cancers in England.  Olaparib, a targeted cancer drug discovered and developed with our funding, has been approved for hundreds of patients with certain breast and prostate cancers in England. 

11 April 2023

• Health & Medicine

Better together: improving brain tumour treatment

We've helped double brain tumour survival over the past 40 years. Now, researchers are combining some of our most successful drugs, temozolomide and PARP inhibitors, to make glioblastoma treatment more effective. We've helped double brain tumour survival over the past 40 years. Now, researchers are combining some of our most successful drugs, temozolomide and PARP inhibitors, to make glioblastoma treatment more effective.

13 February 2023

• Health & Medicine

Women in science: Cancer research pioneers – part 1

As our 20th anniversary year draws to a close, we're celebrating some of the pioneering women who have contributed to impactful cancer research and paved the way for even more. As our 20th anniversary year draws to a close, we're celebrating some of the pioneering women who have contributed to impactful cancer research and paved the way for even more.

18 January 2023

• Health & Medicine

6 highlights from our Black in Cancer conference

Many cancers affect Black people differently. Often, their outcomes are worse. There's a long way to go to change that, but this is how we can start. Many cancers affect Black people differently. Often, their outcomes are worse. There's a long way to go to change that, but this is how we can start.

31 October 2022

• For Researchers

Time to meet our new chief scientist – Professor KJ Patel

As newly appointed chief scientist for Cancer Research UK, Professor KJ Patel brings a wealth of expertise and experience. As newly appointed chief scientist for Cancer Research UK, Professor KJ Patel brings a wealth of expertise and experience.

12 October 2022

• Health & Medicine

NICE doesn’t recommend olaparib for patients with certain prostate cancers

NICE does not recommend olaparib (Lynparza) for people with a type of advanced prostate cancer, as the treatment is not deemed cost-effective NICE does not recommend olaparib (Lynparza) for people with a type of advanced prostate cancer, as the treatment is not deemed cost-effective

13 September 2022

• For Researchers

The award-winning team transforming breast cancer treatment

We spoke to Professor Andrew Tutt about how you build a successful scientific team, the importance of translation and why you always need a touch of humbleness… We spoke to Professor Andrew Tutt about how you build a successful scientific team, the importance of translation and why you always need a touch of humbleness…

10 April 2022

• Health & Medicine

120 years of discovery: 10 ways we’ve changed the story for people with cancer

From a legacy of life-saving medicines to developing new tools to detect cancer, our scientists have been at the forefront of cancer research for 120 years. From a legacy of life-saving medicines to developing new tools to detect cancer, our scientists have been at the forefront of cancer research for 120 years.

2 February 2022